Ameriprise Financial Inc Cassava Sciences Inc Transaction History

Ameriprise Financial Inc

$356 Billion
Q1 2025

A detailed history of Ameriprise Financial Inc transactions in Cassava Sciences Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 15,374 shares of SAVA stock, worth $29,825. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,374

Previous 15,973 3.75%

Holding current value

$29,825

Previous $37,000 37.84%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$1.5 - $3.02 $898 - $1,808	-599 Reduced 3.75%	15,374 $23,000
Q4 2024 Feb 14, 2025	SELL	$2.29 - $32.18 $4,495 - $63,169	-1,963 Reduced 10.94%	15,973 $37,000
Q3 2024 Nov 14, 2024	SELL	$9.57 - $35.08 $19,762 - $72,440	-2,065 Reduced 10.32%	17,936 $527,000
Q2 2024 Aug 14, 2024	BUY	$12.35 - $26.11 $43,756 - $92,507	3,543 Added 21.53%	20,001 $247,000
Q1 2024 May 15, 2024	SELL	$18.44 - $26.41 $11,893 - $17,034	-645 Reduced 3.77%	16,458 $333,000
Q4 2023 Feb 14, 2024	SELL	$12.64 - $30.11 $31,600 - $75,275	-2,500 Reduced 12.75%	17,103 $384,000
Q3 2023 Nov 14, 2023	SELL	$16.64 - $25.32 $124,783 - $189,874	-7,499 Reduced 27.67%	19,603 $326,000
Q2 2023 Aug 14, 2023	SELL	$21.59 - $27.88 $122,458 - $158,135	-5,672 Reduced 17.31%	27,102 $664,000
Q1 2023 May 15, 2023	BUY	$23.46 - $36.44 $593,373 - $921,676	25,293 Added 338.1%	32,774 $790,000
Q4 2022 Feb 14, 2023	BUY	$27.82 - $44.16 $10,293 - $16,339	370 Added 5.2%	7,481 $220,000
Q3 2022 Nov 14, 2022	BUY	$16.33 - $51.06 $116,122 - $363,087	7,111 New	7,111 $298,000
Q1 2022 May 16, 2022	SELL	$32.6 - $53.05 $197,556 - $321,483	-6,060 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$36.77 - $90.91 $202,602 - $500,914	-5,510 Reduced 47.62%	6,060 $265,000
Q3 2021 Nov 15, 2021	BUY	$41.79 - $135.3 $230,639 - $746,720	5,519 Added 91.21%	11,570 $718,000
Q2 2021 Aug 16, 2021	SELL	$32.15 - $89.72 $277,840 - $775,360	-8,642 Reduced 58.82%	6,051 $517,000
Q1 2021 May 17, 2021	BUY	$7.09 - $87.95 $17,441 - $216,357	2,460 Added 20.11%	14,693 $661,000
Q4 2020 Feb 12, 2021	BUY	$6.79 - $12.25 $83,062 - $149,854	12,233 New	12,233 $83,000

Others Institutions Holding SAVA

# of Institutions

155

Shares Held

15.7M

Call Options Held

1.67M

Put Options Held

1.26M

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $77.8M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Cassava Sciences Inc Transaction History